Planet Labs Pbc
Market Movers (8-K)
NYSE
Planet Labs PBC announced the results of its 2026 Annual Meeting of Stockholders, including the re-election of three directors and the ratification of its independent auditor.
NYSE
Planet Labs PBC has entered into an equity distribution agreement to sell up to $1.5 billion of its Class A common stock through an at-the-market offering program.
Capital raise
NYSE
Planet Labs PBC reported record quarterly revenue of $94.2 million, a 42% year-over-year increase, driven by strong backlog growth and successful satellite launches.
NYSE
Planet Labs PBC announced the successful redemption of all outstanding public warrants, resulting in significant cash proceeds and a streamlined capital structure.
NYSE
Planet Labs PBC announced the redemption of all its outstanding public warrants, effective April 27, 2026, at a price of $0.01 per warrant.
Better than expected
Capital raise
NYSE
Planet Labs PBC announced record Q4 and full fiscal year 2026 financial results, achieving its first fiscal year of Adjusted EBITDA and free cash flow profitability, alongside significant growth in revenue and backlog.
Capital raise
Better than expected
Quarterly Earnings (10-Q)
NYSE
Planet Labs PBC announced its first quarter fiscal year 2027 results, with revenue increasing 42% year-over-year to $94.2 million, driven by strong performance in the defense and intelligence sector.
Capital raise
Worse than expected
NYSE
Planet Labs posted 33% revenue growth, positive adjusted EBITDA, a sharp rise in backlog and deferred revenue, and bolstered liquidity with a $460 million convertible note, while GAAP loss widened on non‑cash warrant revaluation.
Capital raise
NYSE
Planet Labs PBC reported a significant reduction in net loss and strong revenue growth for the second quarter of fiscal year 2025, driven by new customer acquisition and expansion in Defense & Intelligence.
Better than expected
Capital raise
NYSE
Planet Labs PBC announced significant financial improvements in its first quarter of fiscal year 2025, including a 57% reduction in net loss and a shift to positive operating cash flow, alongside securing a substantial $230 million commercial agreement with SKY Perfect JSAT.
Capital raise
Better than expected
NYSE
Planet Labs PBC's Q3 2025 results show an 11% increase in revenue compared to the same period last year, driven by customer growth.
Better than expected
NYSE
Planet Labs PBC's second quarter fiscal 2025 results show a 14% increase in revenue year-over-year, alongside a strategic headcount reduction.
Worse than expected
Annual Reports (10-K)
NYSE
Planet Labs PBC filed an amendment to its 2026 Annual Report to include previously omitted director trading plans and compensation recovery policies.
NYSE
Planet Labs PBC reported a 26% increase in revenue to $307.7 million for fiscal year 2026, driven by defense and intelligence contracts, despite recording a net loss of $246.9 million.
Capital raise
Worse than expected
NYSE
Planet Labs PBC announces its fiscal year 2025 results, highlighting an 11% increase in revenue and strategic initiatives for future growth.
Worse than expected
NYSE
Planet Labs PBC's 10-K filing reveals a year of revenue growth alongside continued investments in technology and strategic acquisitions, while also highlighting ongoing challenges in achieving profitability.
Worse than expected
Capital raise
Insider Trading (Form 4)
NYSE
Form 4: Planet Labs PBC CFO Sells Shares
Ashley F. Johnson, President & CFO of Planet Labs PBC, sold 110,028 shares of common stock on July 23, 2026 for $22.08 per share.
NYSE
Kristen Robinson, a Director of Planet Labs PBC, sold 37,107 shares of common stock on July 15, 2026 for $25.05 per share.
NYSE
John W Raymond, a Director of Planet Labs PBC, sold 6,494 shares of common stock on July 13, 2026 for $26.16 per share.
NYSE
Robert H Schingler, Co-Founder Chief Strategy Off. and a Director of Planet Labs PBC, sold 89,593 shares of common stock on July 10, 2026 for $25.92 per share.
NYSE
Form 4: Planet Labs PBC CEO Sells Shares
William Spencer Marshall, Co-Founder and CEO and a Director of Planet Labs PBC, sold 200,000 shares of common stock on July 10, 2026 for $25.92 per share.
NYSE
Planet Labs PBC reports on Form 4 that Director Gary B. Smith acquired restricted stock units, impacting his beneficial ownership.
Proxy Statements (Def-14A)
NYSE
Planet Labs PBC has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing director re-elections, auditor ratification, and executive compensation.
NYSE
Planet Labs PBC announces the election of Scott Reese as a Class II Director to its board, effective 40 days after the information statement distribution.
NYSE
Planet Labs PBC announces the election of Scott Reese as a Class II Director to its board, effective 40 days after September 22, 2025, following approval by majority stockholder written consent.
Better than expected
NYSE
Planet Labs PBC has filed its definitive proxy statement (DEFA14A) with the U.S. Securities and Exchange Commission.
NYSE
Planet Labs PBC has announced its 2025 Annual Meeting of Stockholders for July 10, 2025, where key proposals include director elections and an advisory vote on executive compensation, alongside reporting improved fiscal year 2025 financial performance with increased revenue and significantly reduced net and adjusted EBITDA losses.
Better than expected
NYSE
Planet Labs PBC has appointed General John W. Raymond to its board of directors, effective 40 days after the notice of information statement was sent to stockholders.
Schedule 13D - Activist Investments
NYSE
William Marshall, a key insider at Planet Labs PBC, increased his beneficial ownership to 5.2% of Class A Common Stock following the satisfaction of earnout thresholds.
Schedule 13G - Passive Investments
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Planet Labs PBC following an internal realignment.
NYSE
Driehaus Capital Management LLC has reported a reduced beneficial ownership in Planet Labs PBC, now holding 2.91% of Class A Common Stock.
NYSE
Driehaus Capital Management LLC has reported a 5.01% beneficial ownership stake in Planet Labs PBC's Class A Common Stock as of September 30, 2025.
NYSE
Draper Fisher Jurvetson and affiliated entities, including key individuals, have updated their beneficial ownership in Planet Labs PBC, collectively holding 2.0% of Class A Common Stock as of June 30, 2025, with potential for additional shares based on future stock performance.
NYSE
SCHEDULE 13G/A: Draper Fisher Jurvetson Entities and Principals Disclose Significant Stake in Planet Labs PBC
Multiple Draper Fisher Jurvetson affiliated funds and their principals have filed an amended Schedule 13G, disclosing beneficial ownership of Planet Labs PBC Class A Common Stock, with Timothy C. Draper holding the largest individual stake at 6.2%.